Episode 433: The Singularity Bet, Claude's Protein Breakthrough, and the ICC Under Siege

In this episode, we decode August 19th's seismic shifts across AI infrastructure, biotech, geopolitics, and finance. Stripe's $7 billion acquisition of OpenRouter signals that model routing is now critical payments-layer infrastructure—and hints at the company's belief that 2026 marks the start of 'the singularity.' Anthropic's Claude models achieved breakthrough protein design results, beating industry norms by 2-3x on drug discovery tasks. Moderna's mRNA cancer vaccine prevented melanoma recurrence in late-stage trials, surging the stock 177% and adding $60B in market value. China's Unitree robotics company exploded 542% on its IPO debut, backed by DeepSeek and betting on embodied AI. The Trump administration escalated sanctions on the International Criminal Court, threatening to dismantle it 'brick by brick'—raising existential questions about international justice. OpenAI's CFO confirmed the company will go public by 2027. We also cover Slack's new AI agent collaboration features, Replit's radical Free Mode pricing, the U.S. national debt crossing $40 trillion, and crypto's surge on Trump's pro-crypto signals. This is pattern recognition at the edge of sensemaking: how to be with exponential change across every domain simultaneously. Hosted on Acast. See acast.com/privacy for more information.